This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07991/identifier/pubchem-compound/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07991/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07991/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07991/identifier/chemspider/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/drugbank/drug/DB07991/identifier/pdb/

Statements

Subject Item
n2:DB07991
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB07991 n10:DB07991
dcterms:title
N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE
adms:identifier
n9:20581160 n11:16750040 n12:99444462 n13:DB07991 n14:IOK
n3:IUPAC-Name
n4:271B5360-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5366-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5365-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5362-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5363-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5364-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B535E-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B535F-363D-11E5-9242-09173F13E4C5 n4:271B535C-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B535D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B536C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B536D-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5367-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5368-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B536A-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5369-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B536B-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5372-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5374-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5375-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5371-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5370-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5373-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5361-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B536E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B536F-363D-11E5-9242-09173F13E4C5